Medical device makers divided over reduced tax

Medical device makers are still split over a reduced tax in the Senate health bill, Roll Call reports.

In the fall, congressional Democrats "proposed slapping $40 billion in new taxes over 10 years on the medical device companies, claiming they had refused to offer concessions on their own — in contrast to the drug companies and hospitals — to help pay for health care reform. Industry officials complained they were already taking a hit because of likely hospital cuts that would affect device makers' bottom lines. They warned new taxes would mean steep job losses." But now, as the Senate moves closer to the "final stretch of its consideration of the massive health bill, some in the medical device industry appear closer to reaching a truce. ... Both the Senate and House versions include $20 billion in new taxes on the industry. At the same time, the negotiations have exposed a rift within the medical device community between larger companies and smaller firms" (Roth, 12/16).

Kaiser Health NewsThis article was reprinted from khn.org with permission from the Henry J. Kaiser Family Foundation. Kaiser Health News, an editorially independent news service, is a program of the Kaiser Family Foundation, a nonpartisan health care policy research organization unaffiliated with Kaiser Permanente.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.